PMID: 16640806Apr 28, 2006Paper

Multicenter randomized trial for stage IIIB/IV non-small-cell lung cancer using every-3-week versus weekly paclitaxel/carboplatin

Clinical Lung Cancer
Wolfgang SchuetteDieter Ukena

Abstract

The combination of paclitaxel with carboplatin is effective in advanced-stage non-small cell lung cancer (NSCLC). This phase III study was designed to compare the efficacy and tolerability of a weekly versus an every-3-week schedule in the first-line treatment of advanced-stage NSCLC. Chemotherapy-naive patients were randomized to receive paclitaxel 100 mg/m2 and carboplatin at an area under the curve of 2 once weekly for 6-8 weeks (arm A) or paclitaxel 200 mg/m2 and carboplatin at an area under the curve of 6 on day 1 every 21 days (arm B). A total of 883 patients received >or= 1 chemotherapy cycle and were included in the results. The objective response rates observed (complete response plus partial response) were 38% for arm A and 33% for arm B. Median times to progression and median survival times were 6.1 months and 8.9 months in arm A and 7.2 months and 9.5 months in arm B, respectively. There were no significant differences between treatment arms. The chemotherapy was well tolerated in both schedules. However, grade 3/4 sensory neuropathy occurred more frequently with the every-3-week schedule (9.1% vs. 4.4%), whereas grade 3/4 diarrhea occurred more frequently with the weekly schedule (4.2% vs. 1.1%). In terms of respon...Continue Reading

Citations

Sep 25, 2015·Expert Review of Anticancer Therapy·Mariateresa LapresaNicoletta Colombo
Mar 24, 2007·International Journal of Clinical Oncology·Angeles Alvarez SecordAndrew Berchuck
Nov 22, 2015·Cancer Chemotherapy and Pharmacology·Markus Joerger
Dec 2, 2009·Clinical Journal of Oncology Nursing·Diana Donovan
Nov 15, 2014·Expert Opinion on Drug Metabolism & Toxicology·Markus Joerger
Mar 26, 2014·Cancer Chemotherapy and Pharmacology·Carlos Pérez-RuixoBelén Valenzuela
Dec 5, 2017·Indian Journal of Cancer·UNKNOWN Under the aegis of Lung Cancer Consortium Asia (LCCA)UNKNOWN Molecular Oncology Society (MOS) and Association of Physicians of India API)
Nov 11, 2015·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Viktoria VolkUlrich Mey
Apr 2, 2019·International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group·Mehmet Salih Iyikesici
Nov 18, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Christopher G AzzoliUNKNOWN American Society of Clinical Oncology
Jun 22, 2014·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Celia M Bridges, Ellen M Lavoie Smith
Apr 12, 2019·Cancer Chemotherapy and Pharmacology·Derya Kıvrak SalimPerran Fulden Yumuk
Jun 4, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Tanios S Bekaii-SaabEric H Kraut

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.